Wednesday, July 18, 2018

Sanofi pays $50 million for Revolution Medicines’ SHP2 inhibitor

The partners expect to begin clinical studies of the compound later this year

via Chemical & Engineering News: Biological SCENE https://ift.tt/2NrxDb7
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)